{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Cary",
      "state": "NC",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "66297",
      "recalling_firm": "Triangle Compounding",
      "address_1": "3700 Regency Pkwy Ste 140",
      "address_2": "",
      "postal_code": "27518-8696",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Telephone",
      "distribution_pattern": "NC",
      "recall_number": "D-1068-2013",
      "product_description": "Sodium Phosphate Injectable, 150mM/50mL Phosphorus 200mEq/50mL Sodium, 50 mL Single Dose Vial, Rx only, Triangle Compounding Pharmacy,  3700 Regency Parkway, Suite 140, Cary NC 27518.",
      "product_quantity": "54 Vials",
      "reason_for_recall": "Lack of Assurance of Sterility:The product lots are being recalled due to laboratory results (from a contract lab) indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable. Hence the sterility of the products cannot be assured.",
      "recall_initiation_date": "20130906",
      "center_classification_date": "20130930",
      "termination_date": "20250423",
      "report_date": "20131009",
      "code_info": "Lot #814748-LG14917, Exp 10/31/13",
      "more_code_info": ""
    }
  ]
}